Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
Condition(s) studied
Investigational drug(s) / intervention(s)
colorectal cancer: Patients diagnosed with colorectal cancer by pathological biopsy.
colorectal neoplasm: Patients diagnosed with colorectal adenoma confirmed by colonoscopy.
Study summary
Colorectal cancer is one of the malignant tumours with high morbidity and mortality worldwide, posing a serious threat to human health. In recent years, the incidence of colorectal cancer has been on the rise with changes in lifestyle and dietary habits. Although some progress has been made in treatments such as surgery, chemotherapy and radiotherapy, however, the early diagnosis, prognosis assessment and personalised treatment of colorectal cancer still face great challenges. Therefore, it is of great academic value and practical significance to deeply explore the influencing factors of colorectal cancer occurrence, development and its prognosis, especially the research on environmental factors and metabolomics.
Eligibility
Primary outcome measure(s)
- Rate of postoperative complications — From date of surgery until the date of first documented postoperative complication, assessed up to 2 months after surgery.
Surgical complications was defined as any postoperative complication occurring during the postoperative hospitalisation period.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| the First Affiliated Hospital of Chongqing Medical University | Chongqing | Chongqing Municipality |
More Dong Peng trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06643429 on ClinicalTrials.gov ↗ ← All trials in China